The global market for Influenza Diagnostics market is growing continuously and expected to grow at a CAGR of 5.8% from 2016 to 2023.
The global Influenza Diagnostics market has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. The demand for advanced products is growing continuously. Due to changing disease pattern and increasing cases seasonal flu is leading the market growth for influenza diagnostics. Rapid development in technology and innovation are also major factors for the market growth. The market for Influenza Diagnostics was around US$ 472.2 million in 2016 and is expected to reach US$ 700.7 million at a CAGR of 5.8/% by 2023.
Major Market Players:
- Alere (US),
- BD (US),
- Dickinson and Company (U.S.),
- Cepheid (US),
- bioMérieux SA (France),
- Hardy Diagnostics(us),
- LifeSign LLC.(US),
- Meridian Bioscience, Inc.(US),
- Quidel Corporation (US),
- Roche Molecular Systems Inc.(Switzerland),
- Sekisui Diagnostics (US),
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/3142
All the major players in this market are focusing and investing on R&D to develop new and advanced product for the influenza diagnosis. Changing healthcare practices and rapid adoption of new techniques by the healthcare professionals for the early diagnosis are creating many opportunities in this market. All the major players are competing with each other to capture major stake in this market. On the other hand, many small companies are also holding small but marginable share in this market are also getting into research and development to create innovative and advanced products for the diagnosis of influenza. These players are adopting the strategy of collaboration, distribution agreements among others to expand their network in emerging and potential markets to increase their global presence.
Taste the market data and market information presented through more than 62 market data tables and figures spread over 88 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Influenza Diagnostics Market Research Report –Global Forecast to 2023.”
Increasing funding in R&D and new product development is showing positive impact on market and leading the market growth.
Considering the global scenario of the market, North America is holding the largest market share in global Influenza Diagnostics market in 2016. While the European region captures the second largest share in Global Influenza Diagnostics market. Asia-Pacific will be fastest growing market for Influenza Diagnostics during the forecast period. Middle East and Africa is expected to grow at steady pace during the forecast period.
Global Influenza Diagnostics Market has been segmented on the basis of type of flu which comprise Type A flu (Seasonal flu, Swine Flu, Bird Flu), type B flu, Type C flu. On the basis of type of test it segmented into Molecular Tests, Rapid Influenza Detection Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Nucleic Acid Sequence-based Amplification (NASBA) Tests, Serological Assays, Simple Amplification-based Assays (SAMBA), Loop-mediated Isothermal Amplification-based Assays (LAMP), and Others. Serological assays further sub segmented into Primary Serological tests (Enzyme linked immuno sorben assay (ELISA), Immuno fluorescent antibody technique (IFAT), Radio immuno assay (RIA), Secondary Serological tests (Agglutination tests, Complement fixation tests (CFT), Precipitation tests Serum neutralization tests (SNT), Toxin-antitoxin test), and Tertiary serological tests.
Access Report Details @ https://www.marketresearchfuture.com/reports/influenza-diagnostics-market-3142
Table of Content
- Report Prologue
2.2 Scope of the Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
- Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
- Market Dynamics
Browse Related Statistical Report
The Global connected healthcare market has been evaluated as growing market and expected that the market will touch high growth figures. On the basis of type, the market is segmented into; M-health devices, M-health services and E-prescription. The M-Health Services holds 56.7% market share and expected to reach USD 59.05 billion by 2022 from USD 6.80 billion in 2015. E-prescription is expected to grow at a fastest CAGR of 30.84% from 2016 to 2022.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312